Intraoral delivery of antimicrobials

Drug News and Perspectives

Volumn 18, Issue 6, 2005, Pages 362-374

  Raj, Periathamby Antony ^a   Dentino, Andrew R ^a,b  

^a MARQUETTE UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; ALGINIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ARESTIN; ATRIDOX; CHITOSAN; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; CLOTRIMAZOLE; COPOLYMER; DEFENSIN; DOXYCYCLINE; ETHYLENE VINYL ACETATE COPOLYMER; FLUCONAZOLE; FLUORIDE; HEPARIN; HISTATIN; HYDROXYAPATITE; LISTERINE; METRONIDAZOLE; MINOCYCLINE; NYSTATIN; PERIOCHIP; PERIOGARD; SALIVA PROTEIN; TETRACYCLINE; TOTAL; TRICLOSAN; UNINDEXED DRUG; VASCULOTROPIN; ZINC;

BIOFILM; DRUG DELIVERY SYSTEM; GINGIVITIS; HUMAN; HYDROGEL; IMMUNE SYSTEM; IMMUNOMODULATION; MOUTH DISEASE; MOUTH INFECTION; NONHUMAN; PERIODONTITIS; REVIEW; STOMATITIS; TOOTH PLAQUE;

ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BIOFILMS; CLINICAL TRIALS; DEFENSINS; DENTAL PLAQUE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GINGIVITIS; HUMANS; PEPTIDES, CYCLIC; PERIODONTITIS; PROTEINS; STOMATITIS, DENTURE;

EID: 30444439707     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2005.18.6.927928     Document Type: Review

References (109)

1. Slots, J. and Ting, M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000. 2002, 28: 106-76.
2. Dawes, C. Factors influencing salivary flow rate and composition. In: Saliva and Oral Health. W.M. Edgar, D.M. O'Mullane (Ed.). 2nd ed. British Dental Association, London, 1996, 34.
3. Marsh, P.D. Plaque as a biofilm: Pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis 2003, 9(Suppl 1): 16-22.
4. Socransky, S.S. and Haffajee, A.D. Dental biofilms: Difficult therapeutic targets. Periodontol 2000. 2002, 28: 12-55.
5. Langer, R. Selected advances in drug delivery and tissue engineering. J Control Release 1999, 62: 7-11.
6. Langer, R. Drug delivery and targeting. Nature 1998, 392(6679 Suppl): 5-10.
7. Marsh, P.D. Role of the oral microflora in health. Microb Ecol Health Dis 2000, 12: 130-7.
8. Marsh, P.D. Ed. Oral ecology and its impact on oral microbial diversity. In: Oral Bacterial Ecology: The Molecular Basis. H.K. Kuramitsu, R.P. Ellen (Eds.). Horizon Scientific Press, Wymondham, 2000.
9. Cullinan, M.P., Westerman, B., Hamlet, S.M., Palmer, J.E., Faddy, M.J. and Seymour, G.J. The effect of a triclosan-containing dentifrice on the progression of periodontal disease in an adult population. J Clin Periodontol 2003, 30: 414-9.
10. Rosling, B., Wannfors, B., Volpe, A.R., Furuichi, Y., Ramberg, P. and Lindhe, J. The use of a triclosan/copolymer dentifrice may retard the progression of periodontitis. J Clin Periodontol 1997, 24: 873-80.
11. Fine, D.H., Furgang, D., Bonta, Y. et al. Efficacy of a triclosan/NaF dentifrice in the control of plaque and gingivitis and concurrent oral microflora monitoring. Am J Dent 1998, 11: 259-70.
12. Schiott, C.R., Briner, W.W. and Loe, H. Two year oral use of chlorhexidine in man. II. The effect on the salivary bacterial flora. J Periodontal Res 1976, 11: 145-52.
13. Schiott, C.R., Briner, W.W., Kirkland, J.J. and Loe, H. Two years oral use of chlorhexidine in man. III. Changes in sensitivity of the salivary flora. J Periodontal Res 1976, 11: 153-7.
14. Vroom, J.M., De Grauw, K.J., Gerritsen, H.C. et al. Depth penetration and detection of pH gradients in biofilms by two-photon excitation microscopy. Appl Environ Microbiol 1999, 65: 3502-11.
15. Lowenguth, R.A., Chin, I., Caton, J.G. et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Microbiological response. J Periodontol 1995, 66: 700-7.
16. Drisko, C.L., Cobb, C.M., Killoy, W.J. et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Clinical response. J Periodontol 1995, 66: 692-9.
17. Van der Quderaa, F.J. and Cummins, D. Delivery systems for agents in supra- and sub-gingival plaque control. J Dent Res 1989, 68: 1617-24.
18. Cummins, D. Ed. Mechanisms of action of clinically proven antiplaque agents. In: Clinical and Biological Aspects of Dentifrices. G. Embry, G. Rolls (Eds.). Oxford University Press, Oxford, 1992.
19. Marsh, P.D. Microbiological aspects of the chemical control of plaque and gingivitis. J Dent Res 1992, 71: 1431-8.
20. Shani, S., Friedman, M. and Steinberg, D. The anticariogenic effect of amine fluorides on Streptococcus sobrinus and glucosyl-transferase in biofilms. Caries Res 2000, 34: 260-7.
21. Fine, D.H., Furgang, D. and Barnett, M.L. Comparative antimicrobial activities of antiseptic mouthrinses against isogenic planklonic and biofilm forms of Actinobacillus actinomycetemcomitans. J Clin Periodontol 2001, 28: 697-700.
22. Larsen, T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol 2002, 17: 267-71.
23. Kinniment, S.L., Wimpenny, J.W., Adams, D. and Marsh, P.D. The effect of chlorhexidine on defined, mixed culture oral biofilms grown in a novel model system. J Appl Bacteriol 1996, 81: 120-5.
24. Levine, M.J., Tabak, L., Reddy, M. and Mandel, I.D. Nature of salivary pellicles in microbial adherence: Role of salivary mutins. In: Molecular Basis of Oral Microbial Adhesion. S. Mergenhagen, B. Rosan (Eds.). American Society for Microbiology, Washington D.C., 1985.
25. Antonyraj, K.J., Karunakaran, T. and Raj, P.A. Bactericidal activity and poly-L-proline II conformation of the tandem repeat sequence of human salivary mucin glycoprotein (MG2). Arch Biochem Biophys 1998, 356: 197-206.
26. Raj, P.A. and Dentino, A.R. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett 2002, 206: 9-18.
27. Krisanaprakornkit, S., Kimball, J.R., Weinberg, A., Darveau, R.P., Bainbridge, B.W. and Dale, B.A. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: Multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000, 68: 2907-15.
28. Godowski, K.C., Wolff, E.D., Thompson, D.M. et al. Whole mouth microbiota effects following subgingival delivery of sanguinarium. J Periodontol 1995, 66: 870-7.
29. Loe, H., Theilade, E. and Jensen, S.B. Experimental gingivitis in man. J Periodontol 1965, 36: 177-87.
30. Axelsson, P. and Lindhe, J. The significance of maintenance care in the treatment of periodontal disease. J Clin Periodontol 1981, 8: 281-94.
31. Axelsson, P. and Lindhe, J. Effect of controlled oral hygiene procedures on caries and periodontal disease in adults. Results after 6 years. J Clin Periodontol 1981, 8: 239-48.
32. Axelsson, P. and Lindhe, J. Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. J Clin Periodontol 1987, 14: 205-12.
33. Axelsson, P., Lindhe, J. and Nystrom, B. On the prevention of caries and periodontal disease. Results of a 15-year longitudinal study in adults. J Clin Periodontol 1991, 18: 182-9.
34. Axelsson, P., Nystrom, B. and Lindhe, J. The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance. J Clin Periodontol 2004, 31: 749-57.
35. Kornman, K.S. The role of supragingival plaque in the prevention and treatment of periodontal diseases: A review of current concepts. J Periodontal Res 1986, 21(16S): 5-22.
36. Bauroth, K., Charles, C.H., Mankodi, S.M., Simmons, K., Zhao, Q. and Kumar, L.D. The efficacy of an essential oil antiseptic mouthrinse vs. dental floss in controlling interproximal gingivitis: A comparative study. J Am Dent Assoc 2003, 134: 359-65.
37. Sharma, N.C., Charles, C.H., Qaqish, J.G., Galustians, H.J., Zhao, Q. and Kumar, L.D. Comparative effectiveness of an essential oil mouthrinse and dental floss in controlling interproximal gingivitis and plaque. Am J Dent 2002, 156: 351-5.
38. Sharma, N., Charles, C.H., Lynch, M.C. et al. Adjunctive benefit of an essential oil-containing mouthrinse in reducing plaque and gingivitis in patients who brush and floss regularly: A six-month study. J Am Dent Assoc 2004, 135: 496-504.
39. Dentino, A.R., Kassab, M. and Renner, E. Prevention of Periodontal Diseases. F.A. Scannapieco (Ed.). Dental Clinics of North America, 2005.
40. Rosling, B., Hellstrom, M.K., Ramberg, P., Socransky, S.S. and Lindhe, J. The use of PVP-iodine as an adjunct to non-surgical treatment of chronic periodontitis. J Clin Periodontol 2001, 28: 1023-31.
41. Hujoel, P.P. Endpoints in periodontal trials: The need for an evidence-based research approach. Periodontol 2000. 2004, 36: 196-204.
42. Walker, C.B., Karpinia, K. and Baehni, P. Chemotherapeutics: Antibiotics and other antimicrobials. Periodontol 2000. 2004, 36: 146-65.
43. Christersson, L.A., Albini, B., Zambon, J.J., Wikesjo, U.M. and Genco, R.J. Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. I. Light, immunofluorescence and electron microscopic studies. J Periodontol 1987, 58: 529-39.
44. Christersson, L.A., Wikesjo, U.M., Albini, B., Zambon, J.J. and Genco, R.J. Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. II. Correlation between immunofluorescence and culture techniques. J Periodontol 1987, 58: 540-5.
45. Mellado, J., Freedman, A., Salkin, L., Stein, M., Schneider, D. and Cutler, R. The clinical relevance of microbiological testing: A comparative analysis of microbiologic samples secured from the same site and cultured in two independent laboratories. Int J Periodontics Restorative Dent 2001, 21: 232-9.
46. Newman, M.G., Kornman, K.S. and Doherty, F.M. A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: Clinical results. J Periodontol 1994, 65: 685-91.
47. Michalowicz, B.S., Pihlstrom, B.L., Drisko, C.L. et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Maintenance response. J Periodontol 1995, 66: 708-15.
48. Goodson, J.M. Life on a string: Development of the tetracycline fiber delivery system. Technol Health Care 1996, 4: 269-82.
49. Jeffcoat, M.K., Palcanis, K.G., Weatherford, T.W., Reese, M., Geurs, N.C. and Flashner, M. Use of a biodegradable chlorhexidine chip in the treatment of adult periodontitis: Clinical and radiographic findings. J Periodontol 2000, 71: 256-62.
50. Jeffcoat, M.K., Bray, K.S., Ciancio, S.G. et al. Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. J Periodontol 1998, 69: 989-97.
51. Henke, C.J., Villa, K.F., Aichelmann-Reidy, M.E. et al. An economic evaluation of a chlorhexidine chip for treating chronic periodontitis: The CHIP (chlorhexidine in periodontitis) study. J Am Dent Assoc 2001, 132: 1557-69.
52. De Lissovoy, G., Rentz, A.M., Dukes, E.M. et al. The cost-effectiveness of a new chlorhexidine delivery system in the treatment of adult periodontitis. J Am Dent Assoc 1999, 130: 855-62.
53. Garrett, S., Johnson, L., Drisko, C.H. et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol 1999, 70: 490-503.
54. Garrett, S., Adams, D.F., Bogle, G. et al. The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 months. J Periodontol 2000, 71: 22-30.
55. Williams, R.C., Paquette, D.W., Offenbacher, S. et al. Treatment of periodontitis by local administration of minocycline microspheres: A controlled trial. J Periodontol 2001, 72: 1535-44.
56. Greenstein, G. Conceptualization vs. reality in the treatment of periodontal diseases. Compend Contin Educ Dent 1999, 20: 410-4, 16, 18-20 passim.
57. Budtz-Jorgensen, E. Oral mucosal lesions associated with the wearing of removable dentures. J Oral Pathol 1981, 10: 65-80.
58. Lombardi, T. and Budtz-Jorgensen, E. Treatment of denture-induced stomatitis: A review. Eur J Prosthodont Restor Dent 1993, 2: 17-22.
59. Reichart, P.A. Oral mucosal lesions in a representative cross-sectional study of aging Germans. Community Dent Oral Epidemiol 2000, 28: 390-8.
60. Odds, F. Candida and Candidosis. WB Saunders, Philadelphia, 1988.
61. Edgerton, M., Raj, P.A. and Levine, M.J. Surface-modified poly(methyl methacrylate) enhances adsorption and retains anticandidal activities of salivary histatin 5. J Biomed Mater Res 1995, 29: 1277-86.
62. Webb, B.C., Thomas, C.J., Willcox, M.D., Harty, D.W. and Knox, K.W. Candida-associated denture stomatitis. Aetiology and management: A review. Part 3. Treatment of oral candidosis. Aust Dent J 1998, 43: 244-9.
63. Iacopino, A.M. and Wathen, W.F. Oral candidal infection and denture stomatitis: A comprehensive review. J Am Dent Assoc 1992, 123: 46-51.
64. Ramage, G., Tomsett, K., Wickes, B.L., Lopez-Ribot, J.L. and Redding, S.W. Denture stomatitis: A role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004, 98: 53-9.
65. Edgerton, M., Koshlukova, S.E., Lo, T.E., Chrzan, E.G., Straubinger, R.M. and Raj, P.A. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem 1998, 273: 20438-47.
66. Raj, P.A., Soni, S.D. and Levine, M.J. Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins. J Biol Chem 1994, 269: 9610-9.
67. Frost, P.M., Shirlaw, P.J., Walter, J.D. and Challacombe, S.J. Patient preferences in a preliminary study comparing an intra-oral lubricating device with the usual dry mouth lubricating methods. Br Dent J 2002, 193: 403-8.
68. Frost, P.M., Gardner, R.M., Price, A.R. and Sinclair, G.F. A preliminary assessment of intra-oral lubricating systems for dry mouth patients. Gerodontology 1997, 14: 54-8.
69. Woodley J. Bioadhesion: New possibilities for drug administration? Clin Pharmacokinet 2001, 40: 77-84.
70. Bogataj, M., Mrhar, A. and Korosec, L. Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa. Int J Pharm 1999, 177: 211-20.
71. Lehr, C.M. Lectin-mediated drug delivery: The second generation of bioadhesives. J Control Release 2000, 65: 19-29.
72. Ceschel, G.C., Maffei, P., Lombardi Borgia, S. and Ronchi, C. Design and evaluation of buccal adhesive hydrocortisone acetate (HCA) tablets. Drug Deliv 2001, 8: 161-71.
73. Jain, S.K., Chourasia, M.K., Jain, A.K., Jain, R.K. and Shrivastava, A.K. Develop ment and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. Drug Deliv 2004, 11: 113-22.
74. Muller, R.H. and Jacobs, C. Buparvaquone mucoadhesive nanosuspension: Preparation, optimisation and long-term stability. Int J Pharm 2002, 237: 151-61.
75. Perry, A.C., Rouse, M.S., Khaliq, Y. et al. Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber. Clin Orthop Relat Res 2002: 49-53.
76. Mirth, D.B., Bartkiewicz, A., Shern, R.J. and Little, W.A. Development and in vitro evaluation of an intra-oral controlled-release delivery system for chlorhexidine. J Dent Res 1989, 68: 1285-8.
77. Kalachandra, S., Dongming, L. and Offenbacher, S. Controlled drug release for oral condition by a novel device based on ethylene vinyl acetate (EVA) copolymer. J Mater Sci Mater Med 2002, 13: 53-8.
78. Lin, D.M., Kalachandra, S., Valiyaparambil, J. and Offenbacher, S. A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: Effect of temperature and medium on the rate of drug release. Dent Mater 2003, 19: 589-96.
79. Lee, K.W., Yoon, J.J., Lee, J.H. et al. Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan. Transplant Proc 2004, 36: 2464-5.
80. Van Tomme, S.R., van Steenbergen, M.J., De Smedt, S.C., van Nostrum, C.F. and Hennink, W.E. Self-gelling hydrogels based on oppositely charged dextran microspheres. Biomaterials 2005, 26: 2129-35.
81. Lin, Y.H., Liang, H.F., Chung, C.K., Chen, M.C. and Sung, H.W. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs. Biomaterials 2005, 26: 2105-13.
82. Forsten, L. Fluoride release and uptake by glass-ionomers and related materials and its clinical effect. Biomaterials 1998, 19: 503-8.
83. Williams, J.A., Billington, R.W. and Pearson, G.J. Comparison of ion release from a glass ionomer cement as a function of the method of incorporation of added ions. Biomaterials 1999, 20: 589-94.
84. Hadley, P.C., Billington, R.W. and Pearson, G.J. Effect of monovalent ions in glass ionomer on their uptake and re-release. Biomaterials 1999, 20: 891-7.
85. Itota, T., Okamoto, M., Sato, K. et al. Release and recharge of fluoride by restorative materials. Dent Mater J 1999, 18: 347-53.
86. Williams, J.A., Billington, R.W. and Pearson, G.J. A long term study of fluoride release from metal-containing conventional and resin-modified glass-ionomer cements. J Oral Rehabil 2001, 28: 41-7.
87. Raj, P.A. and Dentino, A.R. Phosphated denture base polymers resist microbial infection. J Dent Res 2003, 82(A): 946.
88. Park, S.E., Periathamby, A.R. and Loza, J.C. Effect of surface-charged poly(methyl methacrylate) on the adhesion of Candida albicans. J Prosthodont 2003, 12: 249-54.
89. Muller, R.H., Jacobs, C. and Kayser, O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001, 47: 3-19.
90. Zimmermann, E. and Muller, R.H. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm 2001, 52: 203-10.
91. Muller, R.H., Radtke, M. and Wissing, S.A. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002, 54(Suppl 1): S131-55.
92. Muller, R.H., Radtke, M. and Wissing, S.A. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002, 242: 121-8.
93. Rogers, T.L., Johnston, K.P. and Williams, R.O., III. Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies. Drug Dev Ind Pharm 2001, 27: 1003-15.
94. Merisko-Liversidge, E., Liversidge, G.G. and Cooper, E.R. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003, 18: 113-20.
95. Brading, M.G. and Marsh, P.D. The oral environment: The challenge for antimicrobials in oral care products. Int Dent J 2003, 53(6 Suppl 1): 353-62.
96. Emerich, D.F. Nanomedicine - Prospective therapeutic and diagnostic applications. Expert Opin Biol Ther 2005, 5: 1-5.
97. Muller, R.H. and Keck, C.M. Challenges and solutions for the delivery of biotech drugs - A review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 2004, 113: 151-70.
98. Tsutsui, J.M., Xie, F. and Porter, R.T. The use of microbubbles to target drug delivery. Cardiovasc Ultrasound 2004, 2: 23.
99. Unger, E.C., McCreery, T.P., Sweitzer, R.H., Caldwell, V.E. and Wu, Y. Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent. Invest Radiol 1998, 33: 886-92.
100. Main, M.L. and Grayburn, P.A. Clinical applications of transpulmonary contrast echocardiography. Am Heart J 1999, 137: 144-53.
101. Miller, M.W. Gene transfection and drug delivery. Ultrasound Med Biol 2000, 26(Suppl 1): S59-62.
102. Fritz, T.A., Unger, E.C., Sutherland, G. and Sahn, D. Phase I clinical trials of MRX-115. A new ultrasound contrast agent. Invest Radiol 1997, 32: 735-40.
103. Unger, E.C., Hersh, E., Vannan, M., Matsunaga, T.O. and McCreery, T. Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 2001, 44: 45-54.
104. Unger, E.C., Matsunaga, T.O., McCreery, T., Schumann, P., Sweitzer, R. and Quigley, R. Therapeutic applications of microbubbles. Eur J Radiol May 2002, 42: 160-8.
105. Amano, A., Kataoka, K., Raj, P.A., Genco, R.J. and Shizukuishi, S. Binding sites of salivary statherin for Porphyromonas gingivalis recombinant fimbrillin. Infect Immun 1996, 64: 4249-54
106. Amano, A., Sharma, A., Lee, J.Y., Sojar, H.T., Raj, P.A. and Genco, R.J. Structural domains of Porphyromonas gingivalis recombinant fimbrillin that mediate binding to salivary proline-rich protein and statherin. Infect Immun 1996, 64: 1631-7.
107. Raj, P.A., Johnsson, M., Levine, M.J. and Nancollas, G.H. Salivary statherin. Dependence on sequence, charge, hydrogen bonding potency, and helical conformation for adsorption to hydroxyapatite and inhibition of mineralization. J Biol Chem 1992, 267: 5968-76.
108. Raj, P. and Dentino, A.R. A novel bifunctional molecule targets oral pathogens. J Dent Res 2002, 81(A): 1491.
109. Raj, P., Rajkumar, L. and Dentino, A.R. New and novel technology for intra-oral delivery of antimicrobials. J Dent Res 2004, 83(A): 1468.